Compare CHGG & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHGG | BTMD |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.6M | 65.4M |
| IPO Year | N/A | N/A |
| Metric | CHGG | BTMD |
|---|---|---|
| Price | $0.54 | $2.07 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $1.50 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.6M | 155.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | ★ N/A | $2.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.44 | $2.02 |
| 52 Week High | $1.90 | $5.00 |
| Indicator | CHGG | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.23 | 38.96 |
| Support Level | $0.67 | $2.02 |
| Resistance Level | $0.81 | $2.19 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 4.45 | 14.08 |
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.